The 4 Stocks That Sank the DJIA on Wednesday

Photo of Paul Ausick
By Paul Ausick Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
The 4 Stocks That Sank the DJIA on Wednesday

© Thinkstock

December 2, 2015: Markets opened mixed on Wednesday and only the Nasdaq Composite was able to remain in positive territory until the afternoon release of the Fed’s Beige Book. U.S. crude oil inventories increased again this week and the coming meeting of OPEC ministers is unlikely to change the cartel’s year-old course of trying to maintain market share. WTI crude for January delivery traded down about 4.6% today to settle at $39.94 per barrel. Gold for February delivery traded down up about 0.9% to settle at $1,053.80 for the day, the yellow metal’s lowest settlement since February 2010. Equities were headed for a lower close shortly before the closing bell as the DJIA traded down 0.93% for the day, the S&P 500 traded down 1.13%, and the Nasdaq Composite traded down 0.63%.

The DJIA stock posting the largest daily percentage loss ahead of the close Wednesday was Exxon Mobil Corp. (NYSE: XOM) which traded down 2.80% at $79.60. The stock’s 52-week range is $66.55 to $95.33. Trading volume was about 25% below the daily average of around 14 million. The strength of the forces currently arrayed against oil producers cannot be overstated.

Chevron Corp. (NYSE: CVX) traded down 2.51% at $90.16. The stock’s 52-week range is $69.58 to $114.82. Trading volume was about 15% below the daily average of about 10 million. U.S. inventories rose again today and the Friday meeting of OPEC oil ministers is adding to the pressure on oil price and even on producers the size of Chevron and Exxon.

Pfizer Inc. (NYSE: PFE) traded down 2.26% at $32.86. The stock’s 52-week range is $28.47 to $36.46. Trading volume was about 35% below the daily average of about 33.4 million. The state of New Jersey is considering taking steps against companies involved in tax inversion deals. Allergan, which is incorporated in Ireland but run from New Jersey, is merging with Pfizer in a tax inversion deal.

JPMorgan Chase & Co. (NYSE: JPM) traded down 1.54% at $66.57. The stock’s 52-week range is $50.07 to $70.61. Volume was about 30% below the daily average of around 14.6 million shares traded. The big bank has kept its employee bonus pool flat with last year’s and teamed up with On Deck Capital for an online lending venture.

Of the Dow 30 stocks 28 are set to close lower today and just 2 are on track to close higher.

ALSO READ: America’s Best and Worst States to Live In

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618